mTOR

metastatic castration-sensitive prostate cancer (7 products)

metastatic hormone sensitive prostate cancer (7 products)

non-metastatic castration-resistant prostate cancer (6 products)

Advanced or metastatic prostate cancer (5 products)

recurrent prostate cancer (3 products)

Prostate cancer (3 products)

metastatic hormone-naive prostate cancer (3 products)

ER+HER2- breast cancer (2 products)

de novo metastatic castration-sensitive prostate cancer (2 products)

Low-risk prostate cancer (2 products)

liver transplantation (1 products)

KRAS G12C-mutated solid tumors (1 products)

recurrent low-grade serous ovarian cancer (1 products)

HER2-negative, hormone-receptor positive metastatic breast cancer (1 products)

metastatic non-small cell lung cancer (1 products)

Stage III melanoma (1 products)

advanced G1/G2 neuroendocrine tumors (1 products)

Metastatic Cancer (1 products)

glioblastoma (1 products)

PSA-recurrent, non-metastatic, non-castrate prostate cancer (1 products)

Prostate cancer with COVID-19 (1 products)

hormone-naive prostate cancer with pelvic lymph node metastases (1 products)

Metastatic CSPC (1 products)

stage IIB/C melanoma (1 products)

recurrent or metastatic cervical cancer (1 products)

recurrent or metastatic head and neck squamous cell carcinoma (1 products)

Newly diagnosed glioblastoma or anaplastic astrocytoma (1 products)